VolitionRX Ltd is a us-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers. The development pipeline includes assays to be used for symptomatic patients or asymptomatic populations. The company has developed ... VolitionRX Ltd is a us-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers. The development pipeline includes assays to be used for symptomatic patients or asymptomatic populations. The company has developed more than 30 blood-based assays to detect specific biomarkers. It also develops Nucleosomics tests for several major cancers including CRC, pancreatic, lung and aggressive prostate. In addition, the company engages in the process of developing HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help decide the appropriate therapy. Show more
VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update PR Newswire HENDERSON, Nev., Nov. 14, 2024 Conference call to discuss financial and operational results...
VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update PR Newswire HENDERSON, Nev., Nov. 8, 2024 Conference call to take place on Friday, November 15 at 8:30...
Volition Appoints Timothy I. Still as Chairman PR Newswire HENDERSON, Nev., Nov. 6, 2024 HENDERSON, Nev., Nov. 6, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a...
Multiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deteriorating PR Newswire HENDERSON, Nev., Oct. 31, 2024 HENDERSON, Nev., Oct. 31, 2024 /PRNewswire/ -- VolitionRx...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0708 | 9.56498243718 | 0.7402 | 0.82 | 0.638 | 177367 | 0.72725683 | CS |
4 | 0.0959 | 13.4107117886 | 0.7151 | 0.82 | 0.55 | 153004 | 0.67802576 | CS |
12 | 0.1359 | 20.1303510591 | 0.6751 | 0.9 | 0.55 | 119020 | 0.69177793 | CS |
26 | 0.0632 | 8.45145760899 | 0.7478 | 0.9 | 0.4301 | 123304 | 0.66321935 | CS |
52 | 0.081 | 11.095890411 | 0.73 | 1.23 | 0.4301 | 166511 | 0.78556036 | CS |
156 | -3.079 | -79.1516709512 | 3.89 | 3.9325 | 0.4301 | 137815 | 1.44121156 | CS |
260 | -4.309 | -84.16015625 | 5.12 | 7.69 | 0.4301 | 184994 | 2.72931814 | CS |
Symbole | Prix | Vol. |
---|---|---|
MSTZT Rex 2X Inverse MSTR Daily Target ETF | US$ 0,6461 (-20,51%) | 24,21M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 26,61 (-1,92%) | 2,72M |
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | US$ 3,18 (3,92%) | 1,96M |
ETHU2x Ether ETF | US$ 7,74 (4,74%) | 1,37M |
SOXSDirexion Daily Semiconductor Bear 3X Shares New | US$ 25,06 (1,75%) | 1,23M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales